SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 2,820.00
-130.00 (-4.41%)
At close: May 7, 2026
SyntekaBio Revenue
In the year 2025, SyntekaBio had annual revenue of 3.43B KRW with 2,736.72% growth. SyntekaBio had revenue of 1.76B in the quarter ending December 31, 2025, with 1,453.94% growth.
Revenue
3.43B
Revenue Growth
+2,736.72%
P/S Ratio
19.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
68.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.43B | 3.31B | 2,736.72% |
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Osangjaiel | 136.35B |
| ISAAC Engineering Co.,Ltd | 78.99B |
| The Asia Business Daily | 73.14B |
| Mr. Blue | 67.46B |
| Seoul Information Service | 41.26B |
| iMBC Co.,Ltd. | 40.05B |
| INITECH | 32.81B |
| SOOSAN INT | 23.89B |